Since July 2012, the U.S. Food and Drug Administration has encouraged the daily use of Truvada in the HIV prevention strategy known as pre-exposure prophylaxis, or PrEP.
Earlier this year, it added the drug Descovy as another daily PrEP option. But newer strategies are emerging for people who struggle with adherence to daily PrEP.Experts still recommend that some high-risk populations take the medication daily to ensure protection.